Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01443533 · ClinicalTrials.gov registry record · NA
Study of Birth Control Use After Childbirth
A NA study, sponsored by WakeMed Health and Hospitals.
- Completed
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT01443533: Completed NA study, sponsored by WakeMed Health and Hospitals.
NCT01443533 is a NA study that has completed, run by WakeMed Health and Hospitals. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01443533, a NA study, has completed, sponsored by WakeMed Health and Hospitals.
- COMPLETED
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial that will evaluate the impact of a brief educational script on the method of birth control that women receive at their 6-week postpartum visit. The one-minute script ("LARC script") is given to women in the hospital during their postpartum admission. It informs patients about long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and the intrauterine device. The investigators hypothesize that women who are randomized to receive the LARC script will be more likely to report that they are using a LARC method, when queried immediately after their six-week postpartum visit.
Interventions
- BEHAVIORAL LARC Script
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT01443533 record still lists
NCT01443533 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 1 intervention - of which LARC Script is the first listed.
NCT01443533 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01443533 about?
NCT01443533 is a clinical study titled "Study of Birth Control Use After Childbirth". This study is a randomized controlled trial that will evaluate the impact of a brief educational script on the method of birth control that women receive at their 6-week postpartum visit. The one-minute script ("LARC script") is given to women in the hospital during their postpartum admission. It in...
What is the current status of trial NCT01443533?
This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01443533?
The interventions under investigation include: LARC Script (BEHAVIORAL).
Who is sponsoring clinical trial NCT01443533?
This trial is sponsored by WakeMed Health and Hospitals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01443533's enrollment target sits among peer trials
800 135th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia